Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthesis process for empagliflozin

A technology of empagliflozin and synthesis process, applied in the field of medicinal chemistry, can solve the problems of high cost and expensive raw materials, and achieve the effects of less impurities, improved purity and easy availability

Inactive Publication Date: 2018-02-02
IANGSU COLLEGE OF ENG & TECH
View PDF8 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] When this route carries out Mg / I exchange, the reaction temperature is better controlled, the reaction conversion rate is higher, and the total yield reaches 54.6%, but the raw materials are more expensive and the cost is higher

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis process for empagliflozin
  • Synthesis process for empagliflozin
  • Synthesis process for empagliflozin

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0045] (1) Preparation of p-bromoacetanilide (I): Dissolve p-bromoacetaniline in water, add dropwise methanol solution of acetic anhydride under ice bath, after the dropwise addition, react at room temperature for 3-5h to prepare p-bromoacetanilide ( I); Concrete reaction is as follows:

[0046]

[0047] (2) Preparation of p-fluorobenzyl bromide (II): Dissolve 4-fluorotoluene and NBS in a solvent, and prepare p-fluorobenzyl bromide (II) in the presence of an initiator; among them, the solvent can be carbon tetrachloride or chloroform Any one of them, preferred toxicity is weaker chloroform as solvent; Initiator can select any one in BPO or AIBN, preferred toxicity is weaker BPO; Concrete reaction is as follows:

[0048]

[0049] (3) Preparation of 4-bromo-2-(4-fluorobenzyl)acetanilide (III): Dissolve p-fluorobenzyl bromide and p-bromoacetanilide in a solvent, catalyzed by Lewis acid, and synthesize 4 -Bromo-2-(4-fluorobenzyl)acetanilide (III); wherein, the solvent can b...

Embodiment 1

[0062] The preparation of embodiment 1 p-bromoacetanilide (I)

[0063] Take 171kg of p-bromoaniline, dissolve it in 300kg of water, stir in ice bath for 30min, add dropwise the methanol solution of acetic anhydride (102kg of acetic anhydride + methanol 200kg), drop it in 30min, after the dropwise addition, stir in ice bath for 1h, then raise the temperature to Continue to react at room temperature for 2 h. After the reaction, filter, wash the filter cake until neutral, and dry to obtain 210 kg of light yellow solid, with a yield of 99%.

Embodiment 2

[0064] Embodiment 2 Preparation of p-fluorobenzyl bromide (II)

[0065] Take 110kg of 4-fluorotoluene, dissolve it in 500kg of chloroform, add 180kg of NBS, add 12kg of BPO, heat up to 70°C for reflux reaction, and react for 6h. After the reaction, cool to room temperature, filter, and recover chloroform from the filtrate under reduced pressure, and distill the residue under reduced pressure 177kg of light yellow liquid was obtained, with a yield of 95%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a synthesis process for empagliflozin. The synthesis process for empagliflozin comprises the following steps: taking 4-fluorotoluene as a starting material; carrying out radical bromo reaction, Friedel-Crafts alkylation reaction, deprotection, diazotization chlorination and alkylation reaction to obtain an intermediate which is (S)-3-(4-(5-bromo-2-chlorobenzyl) phenoxyl) tetrahydrofuran; and then carrying out condensation, etherification and methoxyl removal on the intermediate and 2,3,4,6-quadri-O-trimethylsilyl-D-glucolactone to obtain the empagliflozin as a hypoglycemic drug. The synthesis process for empagliflozin has the advantages that compared with an existing synthesis process, the synthesis process for the empagliflozin takes the 4-fluorotoluene as the starting material, raw materials are cheap and easy to obtain, industrialization is easy to implement in the process, the synthesis route is short, and the process is easy to operate; in a preparation process, various temperature conditions are easy to control, reaction conversion rate is high, and the total yield can be 70% or above; and moreover, by the synthesis process, the product cannot be isomerized easily, impurities are fewer, the purity of the product can be improved, and the purity can be 99% or above.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, in particular to an empagliflozin (2S,3R,4R,5S,6R)-2-[3-[4-[(3S)-tetrahydrofuran]-3-hydroxyphenyl] The synthesis process of methyl]-4-chlorophenyl-6-hydroxymethyloxyhexane-3,4,5-triol. Background technique [0002] Empagliflozin, chemical name: (2S,3R,4R,5S,6R)-2-[3-[4-[(3S)-tetrahydrofuran]-3-hydroxyphenyl]methyl]-4 -Chlorophenyl-6-hydroxymethyloxyhexane-3,4,5-triol, a type 2 sodium glucose cotransporter inhibitor jointly developed by Boehringer Ingelheim and Eli Lilly and Company. SGLT-2 inhibitors are a new type of hypoglycemic drugs, mainly by inhibiting the expression of SGLT-2 in the kidney, reducing the reabsorption of glucose by the kidney, increasing the excretion of glucose in the urine, thereby reducing the plasma glucose level, and its hypoglycemic effect is not good. depends on β Cellular function and insulin resistance. This product was first approved for marketing by the Euro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D407/12
CPCC07D407/12C07B2200/07
Inventor 冯成亮严宾
Owner IANGSU COLLEGE OF ENG & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com